{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-25-002985","form_type":"8-K","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2025-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.837051+00:00","generated_at":"2026-05-17T11:35:54.165327+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Silexion Therapeutics shareholders approve 6x increase in authorized shares to 9M","bullets":["Authorized capital raised from US$20,000 (1,481,482 shares) to US$121,500 (9,000,000 shares).","Vote results: 699,871 for (59.8%), 470,828 against (40.2%), 289,225 abstentions.","Meeting originally Aug 12, 2025, reconvened Aug 19 after no quorum; 16.8% of shares present constituted quorum under Articles.","Memorandum Amendment filed and effective in Cayman Islands on August 19, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-25-002985","json":"https://secwatch.observer/filing/0001178913-25-002985.json","markdown":"https://secwatch.observer/filing/0001178913-25-002985.md","text":"https://secwatch.observer/filing/0001178913-25-002985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002985/0001178913-25-002985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002985/zk2533680.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T11:35:54.165327+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ede15a9f9590c9e0002e90b8723cc2f8bcf4ad3e","claim":"Silexion Therapeutics Corp: Increased authorized share capital via amendment to memorandum of association (effective 2025-08-19).","evidence_excerpt":"the shareholders of the Company duly approved a resolution serving as an effective amendment to paragraph 5 of the Company’s amended and restated memorandum of association (the “ Memorandum Amendment”) , which increased the Company's authorized share capital","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002985/0001178913-25-002985-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-08-19"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}